16 Comments
Jun 29, 2023Liked by Gavin Giovannoni

I love that you share the up-to-date research. The audio explanation of the science coupled with the text allows me to follow along and understand the implications of the research. I was diagnosed later in life (48) and now at 60 am progressing (my walking ability is impacted). I am no longer on any DMTs (Rebif prior). I rely on adjunct therapies (diet, exercise, neuro supplements etc). The science of gene therapies, and re-myelination therapies are relevant to my future. For now, I am all in on the "marginal gains philosophy" and find the science decoded or ordered for emphasis invaluable.

Expand full comment
founding
Jun 29, 2023Liked by Gavin Giovannoni

Good information even when it doesn't apply to me. I was interested to hear that one gene (znfz38) that is involved in MS is involved in intelligence/cognition - reminds me of what Dr. Roy Swank used to say, that people with MS tend to be type A personalities (not intelligence but drive, but still).

Expand full comment
Jun 29, 2023Liked by Gavin Giovannoni

I find the updates super easy to understand on the whole and I have supported the MS Selfie for 2 years. I am not working at the moment, so I am unable to renew my subscription.

My EDSS is 2.0 (according to the MS Register), and my Neurologist has agreed that I have benign MS. I would be interested to hear more on this as I have now been cast aside from the NHS for 2 years. No more appointments or MRIs for me due to the long NHS waiting lists.

I think anyone who has MS needs to have a lot of grit, determination and resilience.

Expand full comment
Feb 17Liked by Gavin Giovannoni

Sharing here as well Prof. G! Such a fantastic post - Thank you!

While I agree that most who have the MS-variants won't develop MS, if you already HAVE MS, the increased risk for your children is substantial. DNA genotyping is essential however, for both the person “with” MS as well as their children.

First, DNA Genotyping for the person “with” MS.

Out of 233 identified genetic variants associated with MS, there are a handful of High-Risk confirmed variants that show MORE than just a “susceptibility” to MS. Depending on which ones and how many you carry, they can show an increased brainstem and cortical pathology, as well as an accelerated timetable in disability.

But that’s only part of the picture…

Having your DNA Genotyped allows you to see other dysregulated cofactors that contribute to the associated symptoms of MS, such as mutations that affect vitamin and mineral absorption and conversion, inflammation, and even DNA repair mechanisms. Knowing which ones allows for targeted supplementation to overcompensate defects – in short, you can fill in the defective gaps and lessen MS associated symptoms. It works. This has been a GAME-CHANGER for me.

For instance, rs1801133: MTHFR (C677T) not only associates with MS risk but plays a part in folate conversion. I carry ALL the MTHFR genes associated with slow folate conversion which also affects cobalamin or b12. Low folate induces symptoms of fatigue, weakness, and neurological issues. B12 deficiency induces symptoms of cognitive impairment, inflammation, neuropathy, muscle weakness, and anemia. All of which are ASSOCIATED WITH COMMON MS SYMPTOMS. I now supplement with high-dose methylated folate and B12 to overcompensate this defect.

A few other HIGH-RISK examples (of many) from my own genotype that I now supplement for: MUC1 gene variants linked to lower blood magnesium levels, gene variants linked to reduced (TMG) betaine production (needed for methylation), GLUL gene variants linked to high oxidative stress and cell damage, NOS3 gene variants of reduced production linked to vascular damage, and on and on.

Not only does DNA Genotyping allow you to supplement to make up for defects, it tells you what NOT to do. As example, for years I supplemented with branched chain amino acids (BCAAs) on gym days, but I now know I carry high-risk gene variants linked to the inability to break BCAAs down, and so, I carry higher levels which cause elevated inflammation. I also carry almost all of the MS confirmed inflammation variants. And here I was, adding even more!

Knowing “what” to supplement and “what not” to supplement helps restore homeostasis in a dysregulated system which, in our case, relieves the severity of common MS symptoms. This only makes sense, because MS is not a single component, but a series of dysfunctional genes that domino across several systems.

Which brings me back to why DNA Genotyping is so important for your children when you “have” MS.

They have an increased risk of developing MS and DNA Genotyping gives them the ability to identify which dysregulated MS associated genes they carry, so they can take preventive measures through supplementation.

What I wouldn’t give for this information before I developed MS. Why wouldn’t I give my children the absolute best chance at avoiding this chronic debilitating disease?

Expand full comment
Jun 30, 2023Liked by Gavin Giovannoni

Thanks for explaining all of this and putting it in perspective!

Expand full comment
Jun 30, 2023Liked by Gavin Giovannoni

Thank you Prof G for this very interesting newsletter.

An unrelated question on which your opinion would be much appreciated: I have had six Ocrevus infusions so far (I was diagnosed with MS at the end of 2019 and started Ocrevus in March 2020, with a four month delay to my third infusion in 2021 in order better to respond to the Covid vaccine). My MS has been stable since I started receiving Ocrevus (putting aside smouldering MS, of course). As I will be traveling, after consulting with my neurologist we agreed that I would postpone my seventh infusion by one month. My neurologist believes that given how long Ocrevus stays in the body, delaying the infusion by one month is fine and implies no MS-related risks. Do you agree?

Expand full comment
Jun 29, 2023Liked by Gavin Giovannoni

Thank you Prof G for a really interesting newsletter.

Expand full comment
founding
Jun 29, 2023Liked by Gavin Giovannoni

Really interesting - thank you Prof G. Is it possible get ones genes analysed to look at possible trajectory of disability or does it not work like that..

Expand full comment
Jun 29, 2023Liked by Gavin Giovannoni

Thank you for the newsletters. I have difficulty understanding written information. Your voice recordings are enjoyable and help greatly with my comprehension. I enjoy all of your updates as I learn something new or I am reminded of important information I had forgotten. Thanks again and have a wonderful weekend. Canada 🇨🇦 day long weekend for us!

Expand full comment
Jun 29, 2023Liked by Gavin Giovannoni

Honestly? I, personally, skim the really sciencey stuff you post. I try to be pragmatic, and I'm just trying to survive. So something that might lead to a treatment in 15 years, that I probably won't be able to access anyway, doesn't effect me.

I closely read anything about current treatments, services, and ways I should modify my own behaviour.

The 'Brain Health' section was interesting for me. I do most of it. But I struggle with exercise because I can barely move. Keto was awful; my cognitive functioning plummeted, so I stopped. I asked my GP if I can get Metformin: he asked why. I explained it's for MS, biohacking, neurologists taking it for anti-ageing; he laughed long and hard... So there's no way I can legally get it, unless there are private doctors who will give it, and that would be expensive.

Social Capital... I'm guessing I have a horrifically low amount. Certainly, the NHS considered me to have zero worth, and if one has no socioeconomic value it's impossible to amass social capital.

Expand full comment
founding
Jun 29, 2023Liked by Gavin Giovannoni

I have a background in medicine but in psychiatry not neurology, genetics or immunology and I am retired so a lot of the areas covered are not familiar to me, discovered well after my time. I certainly get the gist of the newsletters and can drill down into areas that are of more interest. For example my neurologist said enigmatically "you must be a good remyelinator" as I have low EDSS after nearly 35 yrs. It seemed like a good thing to be but now I understand what might be behind it. I think pwMS will gain something at various levels form the News Letters. I have found that best understanding is through reading AND listening at the same time. The audible content seems to give subtle helpful increase in information from tone and emphasis etc but the text gives access to unfamiliar concepts and terms in a way that can be followed up and of course diagrams and charts. Please continue.

Expand full comment
Jun 29, 2023Liked by Gavin Giovannoni

Having also spotted reference to this research just yesterday, I’m very pleased to receive your email this morning, explaining the conclusions in their wider context. It is particularly helpful to have an understanding of the extent of the generic influence as compared with relevant influencers on disease progression such as DMTs and lifestyle factors.

This article provides not only scientific information, but also a degree of reassurance that we are not simply a victim of our genes, but can off-set and benefit ourselves through your recommended lifestyle measures.

Having these kind of posts from you going forward will be helpful - though please do remember, as with all your articles, to put an alert at the outset if the content may cause considerable distress or anxiety - thank you.

Talking of ways of working my brain - I really must listen to some of your articles ProfG and not solely read them!😏

Expand full comment

With no scientific background, I did understand quite a lot of this post, mainly because I’m a follower of Prof G and have learned by reading his blogs. Even although it might be viewed as depressing, I believe this is a good place to educate and discuss.

Expand full comment

I really enjoy all of your newsletters, I studied biomedical science at University so the scientific content level is kind of comfortable for me, and I appreciate that level of information. I work in early phase clinical Research, so I agree that a certain level of context for new findings is important, because as you say, there is a long time before all this could result in having medication available on the NHS.

Expand full comment